Article Text

PDF

Red cell survival after homograft replacement of the aortic valve
  1. M. H. Yacoub1,
  2. M. Kothari,
  3. D. Keeling,
  4. M. Patterson,
  5. D. N. Ross
  1. National Heart Hospital, London, W.1
  2. Middlesex Hospital Medical School, London, W.1

    Abstract

    Red cell survival was studied in 21 patients following homograft replacement of the aortic valve. Autologous cells labelled with 51Cr were used. The T½ 51Cr varied between 24 and 34 days, with only one patient below the normal limit of normal variations. The absence of haemolysis was confirmed by other haematological studies, including estimation of reticulocytes, serum lactic dehydrogenase, and urinary haemosiderin. Haptoglobin levels were low in most of the patients studied. In contrast to prosthetic valves there was no haemolysis in patients with regurgitation around or through the homograft valve.

    Statistics from Altmetric.com

    Footnotes

    • 1 Present address: Department of Cardiovascular Surgery, University of Chicago, 950 E 59th Street, Chicago, Illinois 60637

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.